Skip to content
10-K

Annual Report

Durata Therapeutics, Inc.

0001193125-14-098872

← back to feed
Filed
Mar 14, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 28, 2014 26.64M sh
Capex FY 2013 · Dec 31, 2013 $445K
Capex FY 2013 · Dec 31, 2013 $1.16M
Capex restated FY 2013 · Dec 31, 2012 $719K
Long Term Debt FY 2013 · Dec 31, 2013 $25M
Cash And Equivalents FY 2013 · Dec 31, 2013 $36.85M
Cash And Equivalents restated FY 2013 · Dec 31, 2012 $32.26M
Cash And Equivalents restated FY 2013 · Dec 31, 2011 $11.49M
Cash And Equivalents restated FY 2013 · Dec 31, 2010 $2.26M
Stockholders Equity FY 2013 · Dec 31, 2013 $38.58M
Stockholders Equity restated FY 2013 · Dec 31, 2012 $43.87M
Stockholders Equity restated FY 2013 · Dec 31, 2011 $5.56M
Stockholders Equity FY 2013 · Dec 31, 2010 $1.81M
Stockholders Equity FY 2013 · Dec 31, 2009 $7.29M
Current Liabilities FY 2013 · Dec 31, 2013 $14M
Current Liabilities restated FY 2013 · Dec 31, 2012 $21.5M
Total Liabilities FY 2013 · Dec 31, 2013 $61.57M
Total Liabilities restated FY 2013 · Dec 31, 2012 $42.68M
Current Assets FY 2013 · Dec 31, 2013 $63.1M
Current Assets restated FY 2013 · Dec 31, 2012 $51.2M
Total Assets FY 2013 · Dec 31, 2013 $100.14M
Total Assets restated FY 2013 · Dec 31, 2012 $86.55M
Rd Expense FY 2013 · Dec 31, 2013 $7.12M
Rd Expense FY 2013 · Dec 31, 2013 $37.32M
Rd Expense FY 2013 · Dec 31, 2013 $124.16M
Rd Expense FY 2013 · Sep 30, 2013 $5.93M
Rd Expense FY 2013 · Jun 30, 2013 $13.18M
Rd Expense FY 2013 · Mar 31, 2013 $11.09M
Rd Expense restated FY 2013 · Dec 31, 2012 $9.44M
Rd Expense restated FY 2013 · Dec 31, 2012 $51.7M
Rd Expense restated FY 2013 · Sep 30, 2012 $18.96M
Rd Expense restated FY 2013 · Jun 30, 2012 $16.53M
Rd Expense restated FY 2013 · Mar 31, 2012 $6.77M
Rd Expense restated FY 2013 · Dec 31, 2011 $30.13M
Net Income FY 2013 · Dec 31, 2013 −$15.64M
Net Income FY 2013 · Dec 31, 2013 −$62.14M
Net Income FY 2013 · Dec 31, 2013 −$169.44M
Net Income FY 2013 · Sep 30, 2013 −$11.9M
Net Income FY 2013 · Jun 30, 2013 −$18.84M
Net Income FY 2013 · Mar 31, 2013 −$15.77M
Net Income FY 2013 · Dec 31, 2012 −$13.32M
Net Income restated FY 2013 · Dec 31, 2012 −$62.54M
Net Income FY 2013 · Sep 30, 2012 −$21.77M
Net Income FY 2013 · Jun 30, 2012 −$19.19M
Net Income FY 2013 · Mar 31, 2012 −$8.26M
Net Income restated FY 2013 · Dec 31, 2011 −$33.03M
Net Income restated FY 2013 · Dec 31, 2010 −$11.01M
Net Income restated FY 2013 · Dec 31, 2009 −$714K
Operating Income FY 2013 · Dec 31, 2013 −$12.55M
Operating Income FY 2013 · Dec 31, 2013 −$56.97M
Operating Income FY 2013 · Dec 31, 2013 −$170.14M
Operating Income FY 2013 · Sep 30, 2013 −$11.02M
Operating Income FY 2013 · Jun 30, 2013 −$17.98M
Operating Income FY 2013 · Mar 31, 2013 −$15.43M
Operating Income restated FY 2013 · Dec 31, 2012 −$13.34M
Operating Income restated FY 2013 · Dec 31, 2012 −$62.58M
Operating Income restated FY 2013 · Sep 30, 2012 −$21.79M
Operating Income restated FY 2013 · Jun 30, 2012 −$19.19M
Operating Income restated FY 2013 · Mar 31, 2012 −$8.26M
Operating Income restated FY 2013 · Dec 31, 2011 −$35.56M
Stock Issued FY 2013 · Apr 17, 2013 8.22M sh
Stock Issued FY 2013 · Jul 31, 2012 8.63M sh